These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 27061166)

  • 21. [Continuous intrathecal infusion of baclofen. A new therapeutic method for spasticity].
    Berg-Johnsen J; Røste GK; Solgaard T; Lundar T
    Tidsskr Nor Laegeforen; 1998 Sep; 118(21):3256-60. PubMed ID: 9772811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of intrathecal baclofen in the treatment of spasticity in stroke].
    Lamotte D; Cantalloube S
    Ann Readapt Med Phys; 2007 Apr; 50(3):165-9. PubMed ID: 17145092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathecal baclofen for treatment of intractable spinal spasticity.
    Abel NA; Smith RA
    Arch Phys Med Rehabil; 1994 Jan; 75(1):54-8. PubMed ID: 8291963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal baclofen for spasticity management in Rett syndrome.
    Kadyan V; Clairmont AC; George RJ; Johnson EW
    Am J Phys Med Rehabil; 2003 Jul; 82(7):560-2. PubMed ID: 12819544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrathecal antispastic drug application with implantable pumps: results of a 10 year follow-up study.
    Koulousakis A; Kuchta J
    Acta Neurochir Suppl; 2007; 97(Pt 1):181-4. PubMed ID: 17691374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up.
    Azouvi P; Mane M; Thiebaut JB; Denys P; Remy-Neris O; Bussel B
    Arch Phys Med Rehabil; 1996 Jan; 77(1):35-9. PubMed ID: 8554471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Title: Quantifying the change of spasticity after intrathecal baclofen administration: A descriptive retrospective analysis.
    Pittelkow TP; Bendel MA; Lueders DR; Beck LA; Pingree MJ; Hoelzer BC
    Clin Neurol Neurosurg; 2018 Aug; 171():163-167. PubMed ID: 29913361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Dosing of Intrathecal Baclofen in the Treatment of Spasticity After Acquired Brain Injury.
    Maneyapanda MB; McCormick ZL; Marciniak C; Reger C
    PM R; 2017 Jun; 9(6):556-562. PubMed ID: 28082177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of spasticity in multiple sclerosis by intrathecal baclofen.
    Dario A; Tomei G
    Acta Neurochir Suppl; 2007; 97(Pt 1):189-92. PubMed ID: 17691376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic intrathecal baclofen in severely disabling spasticity: selection, clinical assessment and long-term benefit.
    Pirotte B; Heilporn A; Joffroy A; Zegers de Beyl D; Wesel P; Brotchi J; Levivier M
    Acta Neurol Belg; 1995 Dec; 95(4):216-25. PubMed ID: 8553795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spasticity in a child with myelomeningocele treated with continuous intrathecal baclofen.
    Bergenheim AT; Wendelius M; Shahidi S; Larsson E
    Pediatr Neurosurg; 2003 Oct; 39(4):218-21. PubMed ID: 12944705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin.
    Zahavi A; Geertzen JH; Middel B; Staal M; Rietman JS
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1553-7. PubMed ID: 15489386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity.
    Sampson FC; Hayward A; Evans G; Morton R; Collett B
    J Neurosurg; 2002 Jun; 96(6):1052-7. PubMed ID: 12066906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrathecal baclofen therapy for severe spasticity in an adult with tethered cord syndrome: a case report.
    Takagi Y; Yamada H; Ebara H; Hayashi H; Kidani S; Toyooka K; Ishino Y; Kitano Y; Nakanami A; Kagechika K; Yahata T; Tsuchiya H
    J Med Case Rep; 2021 Sep; 15(1):442. PubMed ID: 34470662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin.
    Armstrong RW; Steinbok P; Cochrane DD; Kube SD; Fife SE; Farrell K
    J Neurosurg; 1997 Sep; 87(3):409-14. PubMed ID: 9285607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of intrathecal baclofen (ITB) therapy in spacticity.
    Ucar T; Kazan S; Turgut U; Samanci NK
    Turk Neurosurg; 2011 Jan; 21(1):59-65. PubMed ID: 21294093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrathecal baclofen for spasticity caused by thrombotic stroke.
    Gwartz BL
    Am J Phys Med Rehabil; 2001 May; 80(5):383-7. PubMed ID: 11327562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study.
    Coffey JR; Cahill D; Steers W; Park TS; Ordia J; Meythaler J; Herman R; Shetter AG; Levy R; Gill B
    J Neurosurg; 1993 Feb; 78(2):226-32. PubMed ID: 8421205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the impact of intrathecal baclofen on the walking ability of people with Multiple Sclerosis related spasticity.
    Sammaraiee Y; Stevenson VL; Keenan E; Buchanan K; Lee H; Padilla H; Farrell RA
    Mult Scler Relat Disord; 2020 Nov; 46():102503. PubMed ID: 33032053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Case report of intrathecal baclofen administration in a child with severe spasticity attributable to traumatic brain injury].
    Matsuda R; Nishimura F; Hirabayashi H; Motoyama Y; Mishima H; Park YS; Nakase H; Sakaki T
    Brain Nerve; 2009 Mar; 61(3):313-5. PubMed ID: 19301603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.